ClinicalTrialsFinder
RecruitingNCT06595992

Prospective Observational Cohort Study of Moderate Aortic Valve Disease

EVOLUTION: Prospective Observational Cohort Study of Moderate Aortic Valve Disease

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Enrollment

1,000 participants

Start Date

Sep 1, 2024

Study Type

OBSERVATIONAL

Conditions

Aortic Valve DiseaseModerate Aortic Valve StenosisModerate Aortic Valve Regurgitation

Summary

The objective of this research is to evaluate and predict the progression of moderate aortic stenosis and regurgitation from clinical characterization, biological, echocardiographic, and computed tomography (CT) et. al. Additionally, try to analyze the potential impact of device or drug therapy on the progression of the conditions.

Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • At least 18 years old
  • Be willing and able to provide informed consent to participate in the study
  • Patient has moderate aortic valve diseases with echocardiographically derived criteria

Exclusion Criteria7

  • Severe aortic valve diseases with echocardiographically derived criteria or planned cardiac surgery or likely need for surgery within 6 months
  • Patients who have undergone elective transfemoral transcatheter aortic valve replacement
  • Life expectancy is less than 12 months due to non-heart disease (such as cancer, chronic liver disease, chronic kidney disease, or chronic end-stage lung disease, etc.)
  • Severe dementia (cannot sign research informed consent, cannot take care of themselves or complete the study visit)
  • Acute pulmonary oedema or cardiogenic shock
  • The investigator believes that the patient is not suitable to participate in the study or complete the follow-up prescribed by the protocol from other medical, social and psychological aspects
  • The patient is currently participating in another randomized study

Locations(1)

Second Affiliated Hospital of Zhejiang University, School of Medicine

Hangzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06595992

Related Trials

SCAPIS 2 Cardio - Vibrometer Based Pulse Wave Analysis and CVD Risk Assessment

NCT070010071 location

Dexamethasone, Olanzapine, Hemodynamics, and Ventilation in Cardiac Surgery

NCT056352271 location

TAVR: The Impact of Prothesis Positioning on Valvular and Coronary Hemodynamics

NCT068962271 location

Post-market Clinical Monitoring of the Safety and Efficacy of the Aortic Valve Bioprothesis

NCT059986941 location

The Effects of 360-degree Virtual Reality on Pre-procedural Anxiety in Patients Awaiting Elective Cardiac Surgery Involving a Sternotomy

NCT060014891 location